Literature DB >> 16043212

Pharmacology and pharmacogenetics of warfarin and other coumarins when used with supplements.

Brian F Gage1, Paul E Milligan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16043212     DOI： 10.1016/j.thromres.2005.06.009

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  4 in total

1.  Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.

Authors:  Howard L McLeod; Daniel J Sargent; Sharon Marsh; Erin M Green; Cristi R King; Charles S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Stephen N Thibodeau; Axel Grothey; Roscoe F Morton; Richard M Goldberg
Journal:  J Clin Oncol       Date:  2010-06-07       Impact factor: 44.544

2.  Meta-analysis of randomized controlled trials reveals an improved clinical outcome of using genotype plus clinical algorithm for warfarin dosing.

Authors:  Zhenqi Liao; Shaoguang Feng; Peng Ling; Guoqing Zhang
Journal:  J Thromb Thrombolysis       Date:  2015-02       Impact factor: 2.300

Review 3.  Warfarin pharmacogenetics.

Authors:  Nita A Limdi; David L Veenstra
Journal:  Pharmacotherapy       Date:  2008-09       Impact factor: 4.705

Review 4.  Oral anticoagulant therapy in patients receiving haemodialysis: is it time to abandon it?

Authors:  Marek Saracyn; Dorota Brodowska-Kania; Stanisław Niemczyk
Journal:  ScientificWorldJournal       Date:  2013-11-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.